Manhattan Scientifics, Inc.
MHTX · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $2 | $1 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $2 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 50% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -12,700% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | -12,700% | – |
| EPS Diluted | -0 | -0.001 | -0.001 | -0.001 |
| % Growth | 57.1% | -40% | 0% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |